PIDTC: Evaluating the Effects of Lentiviral Gene Therapy for Artemis-deficient Severe Combined Immunodeficiency
Feb 22, 2023 ·
2m 4s
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the New England Journal of Medicine on December 22, 2022, titled...
show more
New research from the Primary Immune Deficiency Treatment Consortium (PIDTC). This summary is based on a paper published in the New England Journal of Medicine on December 22, 2022, titled "Lentiviral Gene Therapy for Artemis-Deficient SCID."
Read the paper here: https://www.nejm.org/doi/10.1056/NEJMoa2206575
Learn more about PIDTC: https://pidtc.rarediseasesnetwork.org
show less
Read the paper here: https://www.nejm.org/doi/10.1056/NEJMoa2206575
Learn more about PIDTC: https://pidtc.rarediseasesnetwork.org
Information
| Author | RDCRN |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
